首页> 美国卫生研究院文献>Clinical Epidemiology >Association of Cardiovascular Risk Assessment with Early Colorectal Neoplasia Detection in Asymptomatic Population: A Systematic Review and Meta-Analysis
【2h】

Association of Cardiovascular Risk Assessment with Early Colorectal Neoplasia Detection in Asymptomatic Population: A Systematic Review and Meta-Analysis

机译:无症状人群早期结直肠瘤周期检测心血管风险评估的关联:系统评价和荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Previous studies have shown a strong coexistence of colorectal neoplasia (CRN) and cardiovascular diseases (CVD). This study was aimed to summarize the available evidence on association of CVD risk with early CRN detection in asymptomatic populations. PubMed, Web of Science, and Embase were systematically searched for eligible studies published until Dec 20, 2019. Studies exploring the associations of recommended CVD risk assessment methods (e.g., risk scores, carotid artery plaque, and coronary artery calcium score [CACS]) with risk of CRN were included. Meta-analyses were conducted to determine the overall association of CVD risk with the CRN. A total of 12 studies were finally included. The association of carotid artery plaque with the risk of colorectal adenoma (AD) was weakest (pooled odds ratio [OR)] 1.27, 95% confidence interval [CI), 1.12, 1.45]. Participants with CACS>100 had about 2-fold increased risk of AD than those with CACS=0. The pooled ORs were 3.36 (95% CI, 2.15, 5.27) and 2.30 (95% CI, 1.69, 3.13) for the risk of advanced colorectal neoplasia (AN) and AD, respectively, in participants with Framingham risk score (FRS)>20%, when compared to participants at low risk (FRS<10%). FRS might help identify subgroups at increased risk for AN, but further studies are needed.
机译:以前的研究表明,结直肠瘤形成(CRN)和心血管疾病(CVD)的强烈共存。本研究旨在总结关于CVD风险与无症状群体早期CRN检测的可用证据。系统地搜索PubMed,科学网站和Embase,持续到2019年12月20日出版的合格研究。探索推荐的CVD风险评估方法的协会(例如,风险评分,颈动脉斑块和冠状动脉钙评分[CACS])的研究随着CRN的风险。进行了荟萃分析以确定CVD风险与CRN的整体协会。最后包括12项研究。颈动脉斑块与结直肠腺瘤(AD)风险的关联是最弱的(合并的差距[或)] 1.27,95%置信区间[CI),1.12,1.45]。 CACS> 100的参与者的AD风险大约是2倍,而不是CACS = 0的风险。合并的杂志或分别为3.36(95%CI,2.15,5.27)和2.30(95%CI,1.69,3.13),用于分别在参与者中,在参与者中,参与者的风险,参与者在框架风险评分(FRS) 20%,与低风险(FRS <10%)相比。 FRS可能有助于识别亚组的风险增加,但需要进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号